Dr Reddys Laboratories (RDY) Non Operating Income (2009 - 2023)

Dr Reddys Laboratories (RDY) has reported Non Operating Income for 15 consecutive years, with -$15.0 million the latest figure, recorded in Q2 2023.

• Quarterly Non Operating Income changed N/A year-over-year to -$15.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$34.0 million (changed N/A YoY) and the FY2026 annual result came in at $44.0 million, down 20.0% from the prior year.
• Non Operating Income retreated to -$15.0 million in Q2 2023 per RDY's latest filing, from -$9.0 million in the prior quarter.
• Over the last five years, Non Operating Income for RDY reached as high as $40.0 million in Q1 2019 and fell as low as -$15.0 million in Q2 2023.
• A 5-year average of -$2.5 million and a median of -$7.5 million in 2020 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2019 — Non Operating Income jumped 2100.0% — and 2020, when it sank 120.0%.
• Year by year, Non Operating Income stood at $40.0 million in 2019, then tumbled by 117.5% to -$7.0 million in 2020, then jumped by 42.86% to -$4.0 million in 2021, then tumbled by 150.0% to -$10.0 million in 2022, then tumbled by 50.0% to -$15.0 million in 2023.
• According to Business Quant data, Non Operating Income over the past three periods registered -$15.0 million, -$9.0 million, and -$10.0 million for Q2 2023, Q1 2023, and Q4 2022 respectively.